Blog Archives
Identifying a dominantly inherited pattern of calpainopathy
Limb girdle muscular dystrophy type 2A is the most common limb girdle muscular dystrophy form worldwide. Although strict recessive inheritance is assumed, patients carrying a single mutation in the calpain 3 gene (CAPN3) are reported. Such findings are commonly attributed to incomplete mutation screening. Here, the authors report on 37 individuals (age range: 21-85 … [Read more]
Misregulation of mTOR signaling in dystrophic dystroglycanopathy skeletal muscle
Secondary dystroglycanopathies are a subset of muscular dystrophy caused by abnormal glycosylation of α-dystroglycan (αDG). Loss of αDG functional glycosylation prevents it from binding to laminin and other extracellular matrix receptors, causing muscular dystrophy. Mutations in a number of genes, including FKTN (fukutin), disrupt αDG glycosylation. Here, the authors analyzed conditional Fktn knockout (Fktn KO) … [Read more]
Use of quantitative scores to differentiate demyelinating inflammatory and hereditary neuropathies
This study used ultrasound/electrophysiology of predefined nerves to differentiate between Charcot-Marie Tooth hereditary neuropathy (CMT1) and chronic inflammatory demyelinating polyradiculoneuropathies (CIDP), multifocal motor neuropathy (MMN) and multifocal acquired demyelinating sensory and motor neuropathies (MADSAM) and healthy controls. Ultrasound pattern sum score (UPSS, sum of the amount of 12 predefined measurement points), homogeneity score (HS) … [Read more]
Identification of a novel CMS gene, MYO9A
Congenital myasthenic syndromes (CMS) are a group of rare and genetically heterogenous disorders resulting from defects in the structure and function of the neuromuscular junction. Patients with congenital myasthenic syndrome exhibit fatigable muscle weakness with a variety of accompanying phenotypes depending on the protein affected. A cohort of patients with a clinical diagnosis of congenital … [Read more]
The economic burden of spinal muscular atrophy
This study used Department of Defense Military Healthcare System (MHS) data from 2003-2012 to evaluate the economic burden of spinal muscular atrophy (SMA). Healthcare costs were determined for patients with at least one inpatient or three outpatient claims with a diagnosis of SMA before 18 years of age and who had ≥ 6 months of … [Read more]
Lower-trunk accelerometry to characterize gait pattern abnormalities in patients with DM1
This study evaluated gait using lower-trunk accelerometry and investigated relationships between gait abnormalities, postural instability, handgrip myotonia, and weakness in lower-limb and axial muscle groups commonly affected in myotonic dystrophy type 1 (DM1). Twenty-two patients (11 men, 11 women; age = 42 years (range: 26-51)) with DM1 and twenty healthy controls (9 men, 11 women; age = 44 years … [Read more]
A human pluripotent stem cell model of FSHD-affected skeletal muscles
Facioscapulohumeral muscular dystrophy (FSHD) represents a major unmet clinical need arising from the progressive weakness and atrophy of skeletal muscles. The dearth of adequate experimental models has severely hampered our understanding of the disease. To date, no treatment is available for FSHD. Human embryonic stem cells (hESCs) potentially represent a renewable source of skeletal muscle … [Read more]
Motor function measure and quantitative thigh muscle MRI correlate with clinical function in Becker muscular dystrophy
This cross-sectional study investigated the relation between validated functional scores and quantitative MRI (qMRI) of thigh muscles in 20 ambulatory Becker muscular dystrophy (BMD) patients, aged 18.3-60 years (mean 31.2; SD 11.1). Clinical assessments included the motor function measure (MFM) and its subscales, as well as timed function tests such as the 6-minute walk … [Read more]
Genetically-treated iPS cells for development of autologous stem cell therapy for DM1
This study aimed to develop genome therapy in human Mytonic dystrophy type 1 (DM1) induced pluripotent stem (iPS) cells to eliminate mutant transcripts and reverse the phenotypes for developing autologous stem cell therapy. The general approach involves targeted insertion of polyA signals (PASs) upstream of DMPK CTG repeats, which will lead to premature termination … [Read more]
Idebenone reduces respiratory complications in patients with Duchenne muscular dystrophy
In Duchenne muscular dystrophy (DMD), progressive loss of respiratory function leads to restrictive pulmonary disease and places patients at significant risk for severe respiratory complications. Of particular concerns are ineffective cough, secretion retention and recurrent respiratory tract infections. In a Phase 3 randomized controlled study (DMD Long-term Idebenone Study, DELOS) in DMD patients 10-18 years … [Read more]